Stemness of Human Pluripotent Cells : Hypoxia-Like Response Induced by Low Nitric Oxide
The optimization of conditions to promote the stemness of pluripotent cells in vitro is instrumental for their use in advanced therapies. We show here that exposure of human iPSCs and human ESCs to low concentrations of the chemical NO donor DETA/NO leads to stabilization of hypoxia-inducible factors (HIF-1α and HIF-2α) under normoxia, with this effect being dependent on diminished Pro 402 hydroxylation and decreased degradation by the proteasome. Moreover, the master genes of pluripotency, NANOG and OCT-4, were upregulated. NO also induces a shift in the metabolic profile of PSCs, with an increased expression of hypoxia response genes in glycolysis. Furthermore, a reduction in the mitochondrial membrane potential with lower oxygen consumption and increased expression of mitochondrial fusion regulators, such as DRP1, was observed. The results reported here indicate that NO mimics hypoxia response in human PSCs and enhances their stemness properties when cultured under normoxic conditions.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
Antioxidants (Basel, Switzerland) - 10(2021), 9 vom: 02. Sept. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Caballano-Infantes, Estefanía [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Hypoxia |
|---|
| Anmerkungen: |
Date Revised 01.10.2021 published: Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3390/antiox10091408 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM331146509 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM331146509 | ||
| 003 | DE-627 | ||
| 005 | 20231225212822.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/antiox10091408 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1103.xml |
| 035 | |a (DE-627)NLM331146509 | ||
| 035 | |a (NLM)34573040 | ||
| 035 | |a (PII)1408 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Caballano-Infantes, Estefanía |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Stemness of Human Pluripotent Cells |b Hypoxia-Like Response Induced by Low Nitric Oxide |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 01.10.2021 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a The optimization of conditions to promote the stemness of pluripotent cells in vitro is instrumental for their use in advanced therapies. We show here that exposure of human iPSCs and human ESCs to low concentrations of the chemical NO donor DETA/NO leads to stabilization of hypoxia-inducible factors (HIF-1α and HIF-2α) under normoxia, with this effect being dependent on diminished Pro 402 hydroxylation and decreased degradation by the proteasome. Moreover, the master genes of pluripotency, NANOG and OCT-4, were upregulated. NO also induces a shift in the metabolic profile of PSCs, with an increased expression of hypoxia response genes in glycolysis. Furthermore, a reduction in the mitochondrial membrane potential with lower oxygen consumption and increased expression of mitochondrial fusion regulators, such as DRP1, was observed. The results reported here indicate that NO mimics hypoxia response in human PSCs and enhances their stemness properties when cultured under normoxic conditions | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a hypoxia | |
| 650 | 4 | |a metabolism | |
| 650 | 4 | |a nitric oxide | |
| 650 | 4 | |a normoxia | |
| 650 | 4 | |a pluripotency | |
| 700 | 1 | |a Díaz, Irene |e verfasserin |4 aut | |
| 700 | 1 | |a Hitos, Ana Belén |e verfasserin |4 aut | |
| 700 | 1 | |a Cahuana, Gladys Margot |e verfasserin |4 aut | |
| 700 | 1 | |a Martínez-Ruiz, Antonio |e verfasserin |4 aut | |
| 700 | 1 | |a Soria-Juan, Bárbara |e verfasserin |4 aut | |
| 700 | 1 | |a Rodríguez-Griñolo, Rosario |e verfasserin |4 aut | |
| 700 | 1 | |a Hmadcha, Abdelkrim |e verfasserin |4 aut | |
| 700 | 1 | |a Martín, Franz |e verfasserin |4 aut | |
| 700 | 1 | |a Soria, Bernat |e verfasserin |4 aut | |
| 700 | 1 | |a Tejedo, Juan R |e verfasserin |4 aut | |
| 700 | 1 | |a Bedoya, Francisco Javier |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Antioxidants (Basel, Switzerland) |d 2012 |g 10(2021), 9 vom: 02. Sept. |w (DE-627)NLM256601127 |x 2076-3921 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2021 |g number:9 |g day:02 |g month:09 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/antiox10091408 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2021 |e 9 |b 02 |c 09 | ||